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ABSTRACT
Background: Intracranial space-occupying lesions can be caused by a variety of disease processes, ranging from
neoplasms to non-neoplastic lesions including hematomas, abscesses and vascular malformations. This article provides
an overview of varied clinical presentations of patients with intracranial space-occupying lesions.Methods:A total of
200 cases of intracranial space-occupying lesions presenting at Neuro Clinic and Care were retrospectively analyzed.
Adult patients from all age groups and both genders were included in this study. Results: 165 patients (82.5%) had
neoplastic lesions while 35 (17.5%) had non-neoplastic lesions. Metastatic lesions from primary tumor elsewhere in the
body comprised the most common group with81 cases (40.5%), followed by meningiomas with 27 cases (13.5%).
Males were affected slightly more than females (1:0.8). The most common presenting symptom was headache 87
patients (43.5%,) followed by focal symptoms such as numbness, tingling or weakness being present in 80 (40%)and
seizures observed in 65 (32.5%).Conclusion: The study reviews the wide range of symptoms the patients with intracranial space-occupying lesions present with, the most common being headache, followed by focal symptoms such as
numbness, tingling or weakness, seizures and vomiting. Knowledge of these typical as well as atypical patterns of clinical
presentation can aid physicians in timely detection and prompt application of diagnostic and therapeutic modalities.
Key Words: Intracranial space-occupying lesions, Primary brain tumors, Clinical presentation.
INTRODUCTION

tumors can be classified as gliomas or non-gliomas.
Gliomas account for >80% of primary brain tumors and
include astrocytomas, oligodendrogliomas, ependymomas and mixed oligodendroglial and astrocytic tumors.
Non-gliomas comprise of benign tumors such as meningiomas and pituitary adenomas as well as malignant
tumors such as medulloblastomas, primary CNS
lymphomas and CNS germ cell tumors. The most
common benign brain tumors are meningiomas,
comprising about 20% of primary brain tumors. Astrocytomas including Glioblastoma multiforme (GBM) are the
most common malignant brain tumors (2,3). Almost half
of the brain tumors are primary and the remaining are
metastases that have originated outside the CNS. Brain
metastases are more common than primary malignant
brain tumors and are usually multiple (14). The most
common tumor metastasizing to brain is carcinoma lung
followed by carcinoma breast, colonic carcinoma
and malignant melanoma. Patients with intracranial
space-occupying lesions can present with signs and
symptoms that can be generalized or focal (Table 1).
Focal symptoms are due to localized brain damage and
presentation may indicate location of lesion. These
symptoms include weakness, somatosensory loss, visual

The term “intracranial space-occupying lesion” refers to
neoplasms as well as non-neoplastic lesions.
Neoplasms may be benign or malignant and primary or
metastatic. Non-neoplastic lesions include hematomas,
cerebral abscesses including Toxoplasmosis, cysts
including arachnoid cysts, colloid cysts, dermoid cysts,
epidermoid cysts, vascular malformations and inflammatory or parasitic masses such as cerebral Amoebiasis
and cystecercosis within cranial cavity (1) .Primary malignant tumors of the central nervous system (CNS)
account for approximately 2% of all the primary tumors
of the human body (2, 3). Considerable regional and racial
variations play a role in the difference in the incidence
and pattern of intracranial neoplastic space-occupying
lesions (SOL) throughout the world (1). In most studies
reported from Asian countries, brain tumors occurred
mostly during 4th decade of life while in Western countries, during 5th and 6th decades of life (4-13). Incidence
of brain tumors in the U.S. is 10 per 100,000
person-years, with a male-female ratio of 6:4 (14).Primary
brain tumors are classified on the basis of their histological appearance and cellular orign(3). Primary brain
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Table 1: Presenting Symptoms & Signs in Patients with Intracranial
Space-Occupying Lesions
Generalized
Signs &
Symptoms

False
Localizing &
Lateralizing
Signs

Headache

CN lesions

Nausea,
Vomiting

Horner's
Syndrome
Cerebellar
signs

Seizures
Personality
changes

Localizing Signs & Symptoms
Temporal Lobe:
Behavioral changes
Depersonalization
Hallucinations
Quadrantanopia
Complex partial or generalized
seizures
Frontal Lobe :
Personality changes
Hemiparesis
Expressive aphasia
Anosmia

Change in
mental status
Memory loss
Motor deficits
Sensory
deficits
Deficits of
speech or
vision
Papilledema

Parietallobe:
Spatial disorientation
Hemisensory loss
Receptive aphasia
Hemianopia
Occipital Lobe :
Contralateral hemianopia
Cerebellum:
Ataxia
Dysmetria
Nystagmus
Cerebello-pontine angle
(Acoustic neuroma):
Ipsilateral deafness
Tinnitus
Nystagmus
Ipsilateral cerebellar signs
Facial and Trigeminal palsies
Pituitary tumors:Endocrine symptoms
Visual defects
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and both genders were included in this study. The mean
age of respondents was 50 (SD +/- 2) years. Male
patients constituted 56% (111) and females were 45%
(89), giving a male/female ratio of 1:0.8.Figure 1 shows
that out of 200 cases of intracranial space-occupying
lesions, 82.5% (n=165) were neoplasms, most
common of which were brain metastases (40.5%,
n=81). Meningiomas ranked second with 27 cases
(13.5%) while undifferentiated gliomas (12%, n=24)
were third in frequency. Astrocytomas accounted for
9.5% (n=19) cases and oligodendrogliomas were 3%
(n=6). Acoustic neuromas (Schwannomas) and pituitary
tumors each constituted 2% (n=4) of the lesions.
Among the 17.5% (n=35) cases of non-neoplastic
lesions, the most common was tuberculomas (11%,
n=22) followed by brain abscesses (2%, n=4),
neurocysticercosis and toxoplasmosis, each being 0.5%
(n=1). Fungal granulomas, arteriovenous malformations
and nasopharyngeal mass eroding base of skull
comprised 3.5% of cases (n=7). As depicted in Table 2,
of all the 200 cases of intracranial space-occupying
lesions, the most common clinical presentation was
headache (43.5%, n=87) which was characterized in
most cases as constant, progressive over a period of
weeks or months and moderate to severe in intensity.
Focal symptoms such as numbness, tingling and weakness
occurred in 40% of cases (n=80). Seizures ranked third
in frequency with 32.5% of cases (n=65) and vomiting
occurred in 27.5% of cases (n=55). Speech deficit and
loss of vision or diplopia ranked fifth and sixth in frequency with 15% (n=30) and 13.5% (n=27) cases respectively. 12% of the patients (n=24) had gait disturbances
while 10.5% (n=21) had dizziness. Urine incontinence
was found in 7% of the patients (n=14). Progressive
decline in cognitive functions occurred in 6.5% (n=13)
patients and personality changes were found in 4%
(n=8) of the cases. 3.5% of the cases( of acoustic
neuroma); (n=7) had hearing deficits while only 1%
(n=2) had loss of smell. None of the patients was found
to have loss of taste. Other symptoms such as drowsiness,
unconsciousness, repeated falls, tinnitus, weight loss,
neck pain, dysphagia, generalized weakness and fever
occurred in 52.5% of the patients (n=105). While
evaluating the patients, motor deficits were found to be
the most common presenting sign (Table 3) with 92.5%
of the patients (n=185) showing an increase in tone
and/or a decrease in power, demonstrating signs of
upper motor neuron lesions. Gait disturbances including
heel and toe walking were found in more than half of the
cases (52.5%, n=105). Sensory impairment in pain,
touch, temperature and/or deep pressure sensations
that evaluates integrity of anterior/lateral columns was
found in 2.5% of the patients (n=5) while sensory
impairment in position and vibration sensations evaluating

loss or aphasia and tend to occur in the initial stages of
disease. Generalized symptoms occur as the tumor size
increases and/or when intracranial pressure (ICP) rises.
These symptoms include headache, nausea, vomiting,
seizures, neurocognitive symptoms, personality changes
and false localizing signs (3,15-18). Large lesions in some
locations in the brain (silent regions) may remain
relatively quiescent while a small lesion in dominant
hemisphere may drastically impair speech. A
space-occupying lesion in CNS may infiltrate and
destroy important structures. It can impair cerebrospinal
fluid (CSF) flow causing hydrocephalus or it can induce
formation of new blood vessels leading to vasogenic
edema. In rare instances, intracranial lesions can manifest
with unusual symptoms that range from syncopal
attacks, vertigo, and vestibular neuritis to local symptoms
such as sensory seizures (15), dermatomal hypoesthesia,
ulnar neuropathy (15), trigeminal neuralgia (19) and even
Parkinsonism (20). Physicians could err in their diagnosis
and in formulating treatment plans because of these
unusual presentations.This study aims to enhance the
knowledge regarding the varied clinical presentations of
intracranial space-occupying lesions in adult patients to
allow early diagnosis and prompt treatment. To the best
of our knowledge, current study is one of the few studies
conducted in Pakistan regarding the frequency of intracranial space-occupying lesions and the first study from
Pakistan demonstrating the spectrum of clinical
presentation of intracranial space-occupying lesions in
adults.
METHODOLOGY
The study was carried out retrospectively in which data
from a total of 200 patients with intracranial spaceoccupying lesions; having been collected over a period
of 14 years was reviewed during four months from April
2014 to August 2014 at Neuro Clinic and Care, Karachi,
Pakistan. Adult patients from all ages and both genders
were included in the study. Diagnosis of intracranial
space-occupying lesion was made by either histological
examination (biopsy) or radiological examination (computed tomography or magnetic resonance imaging).Data
was entered and saved onto SPSS version 20. Before
analyzing; data was checked and corrected for any
possible error in data entry. Separate frequency and
valid percentages were calculated for main categorical
variables.
RESULTS
A total of 200 cases of intracranial space-occupying
lesions presenting at Neuro Clinic and Care were retrospectively analyzed. Adult patients from all age groups
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Figure 1: Distribution of 200 cases of intracranial space-occupying lesions

the integrity of posterior column occurred in 14%
(n=28). Cerebellar signs such as nystagmus, positive
finger-nose and heel-shin tests and impaired rapid
alternating movements were present in 24%
(n=48).Level of consciousness was impaired in a quarter
of the patients (25%, n=50) with 27.5% of the patients
(n=55) not oriented to person, place and/or time. Memory
impairment was found in 36.5% of the cases (n=73)
and higher cortical functions that were evaluated by serial
sevens and calculations were also impaired in 36.5%
(n=73). Speech impairment was present in 13.5% of
the cases (n=27). Loss of smell occurred in 1.5%
(n=3). Cranial nerve II impairment demonstrated by
compromised visual acuity, visual fields and by fundoscopic
examination showing papilledema was found in 32%
(n=64). Pupillary response and extraoccular muscle
movements were impaired in 12% of the patients
(n=24). Facial sensations, corneal reflex and Masseter’s
bulk and power (demonstrating integrity of cranial nerve
V) were impaired in 2.5% (n=5) while cranial nerve VII
evaluated by checking facial movements was impaired in
24.5% (n=49). Cranial nerve VIII was evaluated by
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hearing tests (Rinne and Weber ) and was found to be
impaired in 6.5% (n=13). Gag reflex assessing cranial
nerves IX and X was absent in 6% of the cases (n=12).
Only 2 patients (1%) had impaired active and passive
neck movements showing compromised function of
cranial nerve XI while tongue mass and movements
demonstrating intactness of cranial nerve XII were
impaired in 1.5% of the patients (n=3).
DISCUSSION
Both neoplastic and non-neoplastic intracranial
space-occupying lesions share features of clinical
presentation. In a study involving 100 cases of intracranial
space occupying lesions conducted in Lahore,
Pakistan,(1) neoplastic lesions comprised 89% of the
cases while non-neoplastic lesions were reported to be
11%, which gives a similar proportion as in our study of
200 cases comprising of 82.5% neoplastic and 17.5%
non-neoplastic lesions. Males were affected slightly
more than females in their study giving a sex ratio of 1.7:
1, which correlates with the results of our study.
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Some locations are more likely to produce headaches,
for example, infratentorial and intraventricular tumors
were found to cause headache more frequently than a
supratentorial tumor, as a result of impaired CSF flow
causing hydrocephalus and raised ICP resulting in
midline shift (22 ,23) Rapidly growing tumors are more
often associated with headache than slow-growing
tumors. A study that analyzed signs and symptoms of
279 patients with brain tumors pointed out that in only
1/3rd of the patients the site of the tumor coincided with
the lateralization of headache (23).In our study, seizure
activity occurred in 32.5% of the patients which is
similar in frequency to a study conducted in US by Chandana and Movva (3). Seizure activity has been reported in
various studies to be more common in patients with
low-grade gliomas (2,3,15,16). Location of the space-occu-

Table 2: Frequency of different clinical symptoms
of intracranial space-occupying lesions

SYMPTOMS

n

%

Headache
Seizures
Vomiting
Dizziness
Progressive decline in

87
65
55
21

43.5%
32.5%
27.5%
10.5%

13

6.5%

30
8
80
2
27
0
7
24
14

15%
4%
40%
1%
13.5%
0%
3.5%
12%
7%

cognitive functions
Speech deficit
Personality changes
Focal signs/symptoms
Loss of smell
Loss of vision / Diplopia
Loss of taste
Hearing deficits
Gait disturbances
Urine incontinence
Others (drowsiness,
disorientation,
unconsciousness,
repeated falls, tinnitus,
weight loss, neck pain,
dysphagia, generalized
weakness, fever)

105

Table 3: Frequency of different clinical signs of
intracranial space-occupying lesions
SIGNS

52.5%

Headache, the most common presenting symptom in
our study, occurred in 43.5% of the patients. Buckner
et al. pointed out that the new onset of headache that is
constant, progressive, severe, especially worse in the
morning and occurs in association with nausea, vomiting
or focal neurological deficits is more characteristic of an
intracranial space-occupying lesion (2). In patients with
pre-existing headaches, a change in the prior headache
pattern or an increase in their frequency or intensity
suggests presence of an intracranial mass (2, 21).Headache
often occurred in association with other symptoms,
including nausea and vomiting (27.5% of the patients),
visual disturbances (13.5%), gait disturbances( 12%)
and dizziness (10.5%).In a retrospective study of 111
patients conducted by Forsyth and Posner, headaches
were present in 48% of the patients with primary and
metastatic brain tumors, which gives a similar proportion
as in our study. Most headaches (77%) were tension-type
headache while only some were migraine-type (9%) (21).
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n

%

Impaired consciousness

50

25%

Not oriented to person, place and/or
time

55

27.5%

Impaired memory

73

36.5%

Impaired higher cortical functions

73

36.5%

Impaired speech

27

13.5%

CN I:Impaired sense of Smell

3

1.5%

CN II: Papilledema,abnormalities in
visual acuity and visual fields

64

32%

CN III, IV, VI:Restricted Extraoccular
muscle movements and Abnormal
pupillary reflexes

24

12%

CN V: Facial sensation, corneal reflex,
masseter ’s bulk & powerimpairment

5

2.5%

CN VII: Impaired Facial movements

49

25%

CN VIII: Hearing Abnormalities (tested
Weber and Rinne)

13

6.5%

CN IX, X:Abscent gag reflex

12

6%

CN XI:Impaired neck movements

2

1%

CN XII:Abnormalities of tongue mass
and movements

3

1.5%

185

92.5%

5

2.5%

Motor deficits
Sensory deficits–Anterior/Lateral
column (pain, temperature, touch, deep
pressure)
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Sensory deficits–Posterior column
(position, vibration)
Cerebellar signs

28

14%

48

24%

Gait disturbances

105

52.5%
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pying lesion may determine the type of seizure and associated neurologic symptoms.Progressive decline in
cognitive functions as the presenting symptom in
patients with intracranial space-occupying lesions
occurred in 6.5%. Cognitive dysfunction includes changes
in memory, orientation, higher cortical functions and speech.
Personality changes were reported in 4% of the patients.
According to Chandana and Movva, symptoms of cognitive
dysfunction are more likely to herald the presence of an
intracranial lesion in dominant hemisphere than in
non-dominant hemisphere (3). Focal symptoms including
motor and sensory deficits such as numbness, tingling and
weakness was found in 40% of the patients. Patients with
intracranial space-occupying lesions can manifest with
unusual symptoms ranging from syncope attacks, vertigo,
vestibular neuritis, dermatomal hypoesthesia, psychiatric
symptoms to local signs such as sensory seizures and
entrapment neuropathy. Our study demonstrated some
interesting symptoms that patients with intracranial SOLs
may present with. These include loss of smell (1%), hearing
deficits (3.5%) and speech deficits (15%). Similarly, trigeminal
neuralgia has been reported as the initial manifestation of
temporal glioma. The patients presented with episodic,
lancinating facial pain. These intracranial supratentorial
gliomas occurred especially in young patients.19In our
study, functions of trigeminal nerve such as facial
sensations, corneal reflex and Masseter’s bulk and power
were impaired in 2.5% (n=5).Because Glioblastoma Multiforme (GBM) is the most common primary brain tumor, it
has presented in a number of unusual ways such as ulnar
neuropathy, vertigo and syncopal attacks (16), musicogenic
epilepsy and reflex epilepsy (24-26), pseudo-foreign language
syndrome (27, 28), unusual pain syndrome (28) and unusual
personality changes e.g. hypersexuality and anorexia nervosa
(27,29,30)
. GBM of the pineal gland( which is extremely rare at
this location), has been reported to present with hydrocephalus due to compression of the aqueduct of Sylvius and
visual disturbances e.g. horizontal nystagmus and CN VI
palsy (31).Parkinsonism has also been described as a
presenting feature of intracranial space-occupying lesions.
Tumors that infiltrate or compress striatum or substantia
nigra may present with features of Parkinsonism.
Meningiomas are the most common histological type that
can present with it, particularly those with a supratentorial
localization (20).Intracerebral schwannomas, in our study,
made up 2% of all intracranial space-occupying lesions.
These tumors commonly presented with seizures, headache,
nystagmus, tinnitus, hearing loss, facial or trigeminal
palsies. In rare instances, this tumor has been reported to
present as classic temporal lobe epilepsy (33-36).Intracranial
space-occupying lesions can also present with central pain.
Patients with meningioma, low-grade astrocytoma, brain
abscess or arteriovenous malformation causing central pain
due to compression of parietal cortex have been reported in
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literature. Thalamic tumors have also been reported as a
cause of central pain (37).
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